Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1981 1
1983 1
1984 1
1985 2
1986 2
1987 5
1988 3
1989 1
1990 3
1991 1
1992 1
1993 1
1994 2
1995 6
1996 4
1997 3
1998 1
1999 2
2000 2
2001 4
2002 8
2003 7
2004 7
2005 10
2006 6
2007 11
2008 15
2009 8
2010 12
2011 6
2012 9
2013 13
2014 13
2015 8
2016 1
2017 4
2018 2
2019 3
2020 2
2021 1
2022 4
Text availability
Article attribute
Article type
Publication date

Search Results

177 results
Results by year
Filters applied: . Clear all
Page 1
Ibrutinib-Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia.
Shanafelt TD, Wang XV, Kay NE, Hanson CA, O'Brien S, Barrientos J, Jelinek DF, Braggio E, Leis JF, Zhang CC, Coutre SE, Barr PM, Cashen AF, Mato AR, Singh AK, Mullane MP, Little RF, Erba H, Stone RM, Litzow M, Tallman M. Shanafelt TD, et al. Among authors: jelinek df. N Engl J Med. 2019 Aug 1;381(5):432-443. doi: 10.1056/NEJMoa1817073. N Engl J Med. 2019. PMID: 31365801 Free PMC article. Clinical Trial.
Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma.
Kyle RA, Remstein ED, Therneau TM, Dispenzieri A, Kurtin PJ, Hodnefield JM, Larson DR, Plevak MF, Jelinek DF, Fonseca R, Melton LJ 3rd, Rajkumar SV. Kyle RA, et al. Among authors: jelinek df. N Engl J Med. 2007 Jun 21;356(25):2582-90. doi: 10.1056/NEJMoa070389. N Engl J Med. 2007. PMID: 17582068 Free article.
Targeting cancer-associated fibroblasts in the bone marrow prevents resistance to CART-cell therapy in multiple myeloma.
Sakemura R, Hefazi M, Siegler EL, Cox MJ, Larson DP, Hansen MJ, Manriquez Roman C, Schick KJ, Can I, Tapper EE, Horvei P, Adada MM, Bezerra ED, Kankeu Fonkoua LA, Ruff MW, Nevala WK, Walters DK, Parikh SA, Lin Y, Jelinek DF, Kay NE, Bergsagel PL, Kenderian SS. Sakemura R, et al. Among authors: jelinek df. Blood. 2022 Jun 30;139(26):3708-3721. doi: 10.1182/blood.2021012811. Blood. 2022. PMID: 35090171
Long-term Outcomes for Ibrutinib-Rituximab and Chemoimmunotherapy in CLL: Updated Results of the E1912 Trial.
Shanafelt TD, Wang XV, Hanson CA, Paietta EM, O'Brien S, Barrientos JC, Jelinek DF, Braggio E, Leis JF, Zhang CC, Coutre SE, Barr PM, Cashen AF, Mato AR, Singh AK, Mullane MP, Little RF, Erba HP, Stone RM, Litzow MR, Tallman MS, Kay NE. Shanafelt TD, et al. Among authors: jelinek df. Blood. 2022 Apr 15:blood.2021014960. doi: 10.1182/blood.2021014960. Online ahead of print. Blood. 2022. PMID: 35427411 Free article.
Chronic lymphocytic leukemia.
Kay NE, Hamblin TJ, Jelinek DF, Dewald GW, Byrd JC, Farag S, Lucas M, Lin T. Kay NE, et al. Among authors: jelinek df. Hematology Am Soc Hematol Educ Program. 2002:193-213. doi: 10.1182/asheducation-2002.1.193. Hematology Am Soc Hematol Educ Program. 2002. PMID: 12446424 Review.
A-Miz-ing BCL6.
Wu X, Jelinek DF. Wu X, et al. Among authors: jelinek df. Nat Immunol. 2005 Oct;6(10):964-6. doi: 10.1038/ni1005-964. Nat Immunol. 2005. PMID: 16177801 No abstract available.
Regulation of B lymphocyte differentiation.
Jelinek DF. Jelinek DF. Ann Allergy Asthma Immunol. 2000 Apr;84(4):375-85; quiz 385-7. doi: 10.1016/S1081-1206(10)62267-3. Ann Allergy Asthma Immunol. 2000. PMID: 10795645 Review.
Mechanisms of myeloma cell growth control.
Jelinek DF. Jelinek DF. Hematol Oncol Clin North Am. 1999 Dec;13(6):1145-57. doi: 10.1016/s0889-8588(05)70117-9. Hematol Oncol Clin North Am. 1999. PMID: 10626141 Review.
Categorisation of patients based on immune profiles: a new approach to identifying candidates for response to checkpoint inhibitors.
Bornschlegl S, Gustafson MP, Delivanis DA, Ryder M, Liu MC, Vasmatzis G, Hallemeier CL, Park SS, Roberts LR, Parney IF, Jelinek DF, Dietz AB. Bornschlegl S, et al. Among authors: jelinek df. Clin Transl Immunology. 2021 Apr 29;10(4):e1267. doi: 10.1002/cti2.1267. eCollection 2021. Clin Transl Immunology. 2021. PMID: 33968403 Free PMC article.
Myeloma research goes 3D.
Jelinek DF. Jelinek DF. Blood. 2008 Oct 1;112(7):2600-1. doi: 10.1182/blood-2008-06-164178. Blood. 2008. PMID: 18809769 Free article. No abstract available.
177 results